Literature DB >> 15158592

Quantitation of MLV-based retroviral vectors using real-time RT-PCR.

M Carmo1, C Peixoto, A S Coroadinha, P M Alves, P E Cruz, M J T Carrondo.   

Abstract

Murine leukaemia virus-based vectors quantitation is a time consuming process that can take up to five days. In order to reduce this time a real-time RT-PCR was developed. This method quantifies vectors without an RNA extraction step, using AMV reverse transcriptase and LightCycler technology. Besides a low quantitation time, this method has the advantages of using a plasmid DNA standard curve with good reproducibility, and of having a high sensitivity (3 x 10(2) particles/microl) as well as an excellent intra- and inter-assay reproducibility. Although the method described quantifies vector particles with RNA whether these particles are infectious or not, it is possible to use it to determine infectious particles concentration after the establishment of a correlation between particles with RNA and infectious particles, for a given set of conditions. This method can also be used to study vector stability by comparison of infectious particles, total particles and particles with RNA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158592     DOI: 10.1016/j.jviromet.2004.03.007

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells.

Authors:  A F Rodrigues; A S Formas-Oliveira; M R Guerreiro; H A Tomás; P M Alves; A S Coroadinha
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

2.  Development of an enzyme-linked immunosorbent assay based on the murine leukemia virus p30 capsid protein.

Authors:  Dai-Tze Wu; Sriram Aiyer; Rodrigo A Villanueva; Monica J Roth
Journal:  J Virol Methods       Date:  2013-06-26       Impact factor: 2.014

3.  Pseudotyped murine leukemia virus for schistosome transgenesis: approaches, methods and perspectives.

Authors:  Victoria H Mann; Sutas Suttiprapa; Danielle E Skinner; Paul J Brindley; Gabriel Rinaldi
Journal:  Transgenic Res       Date:  2014-01-29       Impact factor: 2.788

4.  Genetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trials.

Authors:  Tulin Budak-Alpdogan; Isabelle Rivière
Journal:  Methods Mol Biol       Date:  2009

5.  Establishing transgenic schistosomes.

Authors:  Victoria H Mann; Sutas Suttiprapa; Gabriel Rinaldi; Paul J Brindley
Journal:  PLoS Negl Trop Dis       Date:  2011-08-30

6.  The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus.

Authors:  Yeong Jun Kim; Ui Soon Jang; Sandrine M Soh; Joo-Youn Lee; Hye-Ra Lee
Journal:  Viruses       Date:  2021-04-07       Impact factor: 5.048

7.  Viral Vector-Based Targeting of miR-21 in Cardiac Nonmyocyte Cells Reduces Pathologic Remodeling of the Heart.

Authors:  Deepak Ramanujam; Yassine Sassi; Bernhard Laggerbauer; Stefan Engelhardt
Journal:  Mol Ther       Date:  2016-08-22       Impact factor: 11.454

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.